Inactive Instrument
Quotes Merrimack Pharmaceuticals
Stocks
MACK
US5903282094
Biotechnology & Medical Research
Stock exchange
Nasdaq
MACK 15.13 $
-.--%
19M
$
| Markets | Price | Change | Volumes |
|---|
Performance
| 3 years | +22.91% | ||
| 5 years | +242.31% | ||
| 10 years | -73.27% |
Volumes
marketsCapital turnover ratio
0.03
Float rotation
0.03
Basic data
Market Cap (USD)
223,748,022
Number of employees
27
Sales / Employee ()
0
Sales / Employee (USD)
0
Free-Float
98.81%
Free-Float capitalization (USD)
221,082,736
Average Daily Capital Traded
3.39%
Indicators
Moving average 5 days
15.12
Moving average 20 days
14.95
Moving average 50 days
14.81
Moving average 100 days
14.3
Price spread / (MMA5)
-0.07%
Price spread / (MMA20)
-1.19%
Price spread / (MMA50)
-2.12%
Price spread / (MMA100)
-5.49%
RSI 9 days
82.79
RSI 14 days
78.97
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -.--% | -.--% | +22.91% | 224M | |
| -6.60% | -8.56% | +42.79% | +64.16% | 65B | |
| -4.09% | -0.11% | +2.22% | +53.15% | 51.19B | |
| +0.03% | +5.56% | +10.18% | +41.75% | 51.2B | |
| -1.53% | +2.70% | +30.48% | +34.12% | 43.93B | |
| -1.34% | +4.12% | +16.64% | +115.13% | 41.96B | |
| -5.97% | -6.22% | +228.95% | +454.22% | 38.14B | |
| +6.53% | +8.02% | +15.74% | +53.94% | 33.24B | |
| -0.90% | -10.49% | +31.48% | -1.63% | 25.2B | |
| -2.76% | -9.54% | -16.58% | -9.19% | 22.03B | |
| Average | -1.66% | -1.67% | +36.19% | +82.86% | 37.21B | |
| Weighted average by Cap. | -2.30% | -1.21% | +40.68% | +92.01% |
Historical Quotes: Merrimack Pharmaceuticals
| Date | Opening | High | Low | Close | Volume | Change |
|---|
Price Extremes
| 3 years | 12 |  | 15.89 |
| 5 years | 3 | | 15.89 |
| 10 years | 1.49 | | 67.9 |
Monthly variations
Annual variations
| 2024 | +12.83% | ||
| 2023 | +17.02% | ||
| 2022 | +193.09% | ||
| 2021 | -43.25% | ||
| 2020 | +118.73% | ||
| 2019 | -18.39% | ||
| 2018 | -62.34% | ||
| 2017 | -74.88% | ||
| 2016 | -48.35% | ||
| 2015 | -30.09% | ||
| 2014 | +111.97% | ||
| 2013 | -12.46% | ||
| 2012 | +0.83% |
